Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Autoimmune Disorders

  Free Subscription


18.05.2020

1 Acta Neurol Scand
1 BMC Neurol
2 Brain
1 Curr Opin Immunol
1 Diabetes Res Clin Pract
1 J Autoimmun
2 J Clin Endocrinol Metab
1 J Nephrol
3 J Neurol
1 J Rheumatol
1 Lancet Child Adolesc Health
6 Lancet Diabetes Endocrinol
5 Mult Scler
1 N Engl J Med
1 PLoS Biol
2 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. COSTA ARPIN E, Naveiro Soneira J, Lema Bouzas M, Quintela AG, et al
    Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
    Acta Neurol Scand. 2020 May 11. doi: 10.1111/ane.13265.
    PubMed         Abstract available


    BMC Neurol

  2. GRAVESTEIJN AS, Beckerman H, de Jong BA, Hulst HE, et al
    Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.
    BMC Neurol. 2020;20:177.
    PubMed         Abstract available


    Brain

  3. MALPAS CB, Manouchehrinia A, Sharmin S, Roos I, et al
    Early clinical markers of aggressive multiple sclerosis.
    Brain. 2020 May 9. pii: 5835340. doi: 10.1093.
    PubMed         Abstract available

  4. FRANSEN NL, Hsiao CC, van der Poel M, Engelenburg HJ, et al
    Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Brain. 2020 May 13. pii: 5836675. doi: 10.1093.
    PubMed         Abstract available


    Curr Opin Immunol

  5. SHIPMAN WD, Sandoval MJ, Veiga K, Donlin LT, et al
    Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblasts.
    Curr Opin Immunol. 2020;64:63-70.
    PubMed         Abstract available


    Diabetes Res Clin Pract

  6. SOMALI M, Paschou SA, Mouslech Z
    Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus.
    Diabetes Res Clin Pract. 2020;160:108026.
    PubMed         Abstract available


    J Autoimmun

  7. CARL PL, Fried HM, Cohen PL
    Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.
    J Autoimmun. 2020 May 11:102471. doi: 10.1016/j.jaut.2020.102471.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  8. BJORVATN SAEVIK A, Akerman AK, Methlie P, Quinkler M, et al
    Residual Corticosteroid Production in Autoimmune Addison's Disease.
    J Clin Endocrinol Metab. 2020 May 11. pii: 5835888. doi: 10.1210.
    PubMed         Abstract available

  9. PAPARODIS RD, Bantouna D, Karvounis E, Imam S, et al
    Higher TSH is not associated with thyroid cancer risk in the presence of thyroid autoimmunity.
    J Clin Endocrinol Metab. 2020 May 11. pii: 5835732. doi: 10.1210.
    PubMed         Abstract available


    J Nephrol

  10. ZHANG J, Mi Y, Zhou R, Liu Z, et al
    The TLR4-MyD88-NF-kappaB pathway is involved in sIgA-mediated IgA nephropathy.
    J Nephrol. 2020 May 9. pii: 10.1007/s40620-020-00722.
    PubMed         Abstract available


    J Neurol

  11. TSANTES E, Curti E, Ganazzoli C, Puci F, et al
    The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
    J Neurol. 2020 May 12. pii: 10.1007/s00415-020-09894.
    PubMed         Abstract available

  12. KIM JG, Lee SU, Lee CN, Yu SW, et al
    Bilateral vestibulopathy as an early manifestation of systemic lupus erythematosus.
    J Neurol. 2020 May 11. pii: 10.1007/s00415-020-09876.
    PubMed        

  13. KOCH MW, Mostert J, Greenfield J, Liu WQ, et al
    Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
    J Neurol. 2020 May 9. pii: 10.1007/s00415-020-09895.
    PubMed         Abstract available


    J Rheumatol

  14. CHEN C, Yao B, Yan M, Su K, et al
    The plight of patients with lupus nephritis in Wuhan, China.
    J Rheumatol. 2020 May 8. pii: jrheum.200452. doi: 10.3899/jrheum.200452.
    PubMed         Abstract available


    Lancet Child Adolesc Health

  15. LANGE K, Kordonouri O
    Setting the right course at type 1 diabetes diagnosis.
    Lancet Child Adolesc Health. 2019 Jan 28. pii: S2352-4642(19)30031.
    PubMed        


    Lancet Diabetes Endocrinol

  16. ZAHARIA OP, Kuss O, Strassburger K, Burkart V, et al
    Diabetes clusters and risk of diabetes-associated diseases - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:828-829.
    PubMed        

  17. D'AIUTO F, Deanfield JE
    Intensive periodontal therapy and type 2 diabetes - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:175-176.
    PubMed        

  18. GILLARD P, Charleer S, Mathieu C
    Glycaemic control on nutritional support: finding stability in unstable times.
    Lancet Diabetes Endocrinol. 2019 Mar 29. pii: S2213-8587(19)30094.
    PubMed        

  19. HERMANNS N, Ehrmann D, Kulzer B
    Continuous glucose monitoring-based technologies in hypoglycaemia-prone patients with type 1 diabetes.
    Lancet Diabetes Endocrinol. 2019 Apr 29. pii: S2213-8587(19)30146.
    PubMed        

  20. HEERSPINK HJL
    Predicting individual treatment response in diabetes.
    Lancet Diabetes Endocrinol. 2019 Apr 29. pii: S2213-8587(19)30118.
    PubMed        

  21. DENNIS JM, Shields BM, Henley WE, Jones AG, et al
    Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:669.
    PubMed        


    Mult Scler

  22. GHARAKHANLOU R, Wesselmann L, Rademacher A, Lampit A, et al
    Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials.
    Mult Scler. 2020 May 11:1352458520917935. doi: 10.1177/1352458520917935.
    PubMed         Abstract available

  23. KILJAN S, Preziosa P, Jonkman LE, van de Berg WD, et al
    Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study.
    Mult Scler. 2020 May 11:1352458520918978. doi: 10.1177/1352458520918978.
    PubMed         Abstract available

  24. VALBURG C, Sonti A, Stern JN, Najjar S, et al
    Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review.
    Mult Scler. 2020 May 14:1352458520923955. doi: 10.1177/1352458520923955.
    PubMed         Abstract available

  25. BRUIJSTENS AL, Blok KM, Smolders J, Wokke BH, et al
    Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment.
    Mult Scler. 2020 May 14:1352458520921367. doi: 10.1177/1352458520921367.
    PubMed        

  26. LAMBE J, Saidha S, Bermel RA
    Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials.
    Mult Scler. 2020;26:624-639.
    PubMed         Abstract available


    N Engl J Med

  27. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    PubMed        


    PLoS Biol

  28. WELSH RA, Song N, Foss CA, Boronina T, et al
    Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases.
    PLoS Biol. 2020;18:e3000590.
    PubMed         Abstract available


    PLoS One

  29. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed         Abstract available

  30. AUNGSUMART S, Apiwattanakul M
    Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    PLoS One. 2020;15:e0229028.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  31. STANBERY AG, Newman ZR, Barton GM
    Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-gamma.
    Proc Natl Acad Sci U S A. 2020;117:3074-3082.
    PubMed         Abstract available

  32. MORIANOS I, Trochoutsou AI, Papadopoulou G, Semitekolou M, et al
    Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-alpha-dependent pathways.
    Proc Natl Acad Sci U S A. 2020 May 14. pii: 1918196117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: